Regulatory Affairs

HYOGO, Japan — September 28, 2026 JCR Pharmaceuticals Co., Ltd. announced that Japan’s Ministry of Health, Labour and Welfare...

GEORGETOWN, Texas — September 15, 2026 AustinPx announced that the U.S. Food and Drug Administration’s Center for Drug Evaluation...

Singapore, September 21, 2026 Specialised Therapeutics (ST) has expanded its existing partnership with Incyte to include ruxolitinib cream (Opzelura®)...

Taipei, Taiwan, September 11, 2026 Avance Clinical has received the Australia-Taiwan Business Excellence Award from the Australia New Zealand...

San Francisco, California, USA, September 9, 2026 Eir Partners has acquired Accumulus Technologies, marking a new phase of growth...

Edmonton, Alberta, Canada, September 2, 2026 Aurora Cannabis Inc., a global medical cannabis company, has urged its shareholders to...

North Chicago, Illinois, United States, Aug. 27, 2026 AbbVie has submitted a regulatory application to the European Medicines Agency...

ROTKREUZ, Switzerland, July 31, 2026 Polpharma Biologics International AG announced that the U.S. Food and Drug Administration (FDA) and...

PARIS, France, July 30, 2026 Abivax SA announced the successful completion of a positive pre-New Drug Application (pre-NDA) interaction...

SILVER SPRING, Maryland, July 10, 2026 The U.S. Food and Drug Administration (FDA) has proposed a new rule designed...